Potential Upside For Christina Lake Cannabis Corp. (CSE:CLC) Not Without Risk

When you see that almost half of the companies in the Pharmaceuticals industry in Canada have price-to-sales ratios (or “P/S”) above 1.1x, Christina Lake Cannabis Corp. (CSE:CLC) looks to be giving off some buy signals with its 0.6x P/S ratio. However, the P/S might be low for a reason and it requires further investigation to determine if it’s justified.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

View our latest analysis for Christina Lake Cannabis

What Does Christina Lake Cannabis’ P/S Mean For Shareholders?

The revenue growth achieved at Christina Lake Cannabis over the last year would be more than acceptable for most companies. It might be that many expect the respectable revenue performance to…